Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03496818 · ClinicalTrials.gov registry record
Effect of SB CD on Chylomicron
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 47
- Enrollment target
NCT03496818 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 47 participants.
The verdict
NCT03496818 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
It is often suggested that lymphatic vessels are ineffective in transporting cargo in Crohn's disease. Our own work on surgically resected tissue supports this concept (1), but the concept has not been directly tested. Chylomicrons are packaged lipids from the diet with an obligatory absorption route through the lymphatic vasculature to reach host plasma. This protocol takes an approach to directly quantify chylomicron secretion using a fatty meal that incorporates stable isotopic tracers for trioleate and cholesterol in the meal. We will collect baseline plasma and then plasma every 30 minutes for 6 hours to chart the kinetic and magnitude of chylomicron secretion and transport in all subjects using mass spectrometry analysis. We will characterize a wide variety of parameters on the chylomicrons as well using ELISA. Infusions i.v. of stable isotope labeled triglyceride and glycerol will allow us to consider whether there are changes in VLDL metabolism that could account for differences in chylomicron handling once the chylomicrons are secreted into plasma. Collection and analysis of breath samples will also be carried to normalize against possible incomplete lipid absorption in some subjects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2018-04-16 |
| Est. Completion | 2020-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03496818
The ClinicalTrials.gov registry entry for NCT03496818 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03496818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03496818 about?
NCT03496818 is a clinical study titled "Effect of SB CD on Chylomicron". It is often suggested that lymphatic vessels are ineffective in transporting cargo in Crohn's disease. Our own work on surgically resected tissue supports this concept (1), but the concept has not been directly tested. Chylomicrons are packaged lipids from the diet with an obligatory absorption rout...
What is the current status of trial NCT03496818?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2018-04-16. Estimated completion is 2020-06-01.
Who is sponsoring clinical trial NCT03496818?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.